DarkHorse Podcast

Haunted by the Hanta Virus: The 325th Evolutionary Lens with Bret Weinstein and Heather Heying

75 snips
May 9, 2026
They dig into hantavirus natural history, transmission routes, and puzzling shipboard cases. They debate ivermectin as a potential antiviral and why WHO and big biotechs respond the way they do. They examine Moderna’s vaccine work and the economics behind vaccine rollouts. They challenge official drought declarations using regional water metrics and bureaucratic incentives.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Systematic Review Finds Little Evidence For Human Spread

  • A systematic review found scant evidence for human-to-human transmission except weak, biased signals for one South American strain.
  • Heather Heying cites the Journal of Infectious Diseases review concluding overall evidence does not support routine human-to-human spread.
INSIGHT

RNA Virus Evolution Explains Lab Focus

  • Single-stranded RNA viruses evolve fast, making them preferred targets for gain-of-function experiments.
  • Bret links that evolutionary property to why labs focus on RNA viruses and why ivermectin discussions recur.
ADVICE

Consider Ivermectin Early For Single Stranded RNA Exposure

  • Consider ivermectin as a low-risk, plausible early treatment for single-stranded RNA infections pending trials.
  • Bret argues its safety profile makes even a small chance of benefit worth using for exposed people.
Get the Snipd Podcast app to discover more snips from this episode
Get the app